Filing Details

Accession Number:
0001209191-19-035525
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-06-07 16:12:20
Reporting Period:
2019-06-06
Accepted Time:
2019-06-07 16:12:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1645460 Cue Biopharma Inc. CUE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1190121 R Daniel Passeri 21 Erie Street
Cambridge MA 02139
Ceo And President Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-06-06 3,000 $6.90 50,600 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.88 to $6.92, inclusive. The reporting person undertakes to provide to Cue Biopharma, Inc., any security holder of Cue Biopharma, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.